What is the most recent earnings date for AMRX stock?
AMNEAL PHARMACEUTICALS INC (AMRX) last reported earnings on 2/27/2026.
AMNEAL PHARMACEUTICALS INC (AMRX) Earnings History & Surprises
NASDAQ:AMRX • US03168L1052
Current stock price
12.295 USD
-0.1 (-0.77%)
Last:
AMRX Earnings overview
Past quarterly earnings results for AMNEAL PHARMACEUTICALS INC (AMRX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.17
- Revenue Estimate
- 727.81M
Last Reported
Most Recent- Release Date
- Feb 27, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.21
- EPS Surprise
- 11.53%
- Revenue Surprise
- -1.18%
Beat Rate
Last 8 Quarters 63%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.21 | 0.19 | 11.53% | 75.00% | 814.319M | 824.05M | -1.18% | 11.47% |
| Q3 2025 | 0.17 | 0.14 | 21.21% | 6.25% | 784.513M | 787.76M | -0.41% | 11.68% |
| Q2 2025 | 0.25 | 0.18 | 40.06% | 56.25% | 724.508M | 759.45M | -4.60% | 3.24% |
| Q1 2025 | 0.21 | 0.15 | 40.37% | 50.00% | 695.42M | 729.8M | -4.71% | 5.50% |
| Q4 2024 | 0.12 | 0.16 | -22.85% | -14.29% | 730.518M | 721.7M | 1.22% | 18.40% |
| Q3 2024 | 0.16 | 0.14 | 16.19% | -15.79% | 702.468M | 710.73M | -1.16% | 13.29% |
| Q2 2024 | 0.16 | 0.14 | 13.26% | -15.79% | 701.78M | 671.3M | 4.54% | 17.15% |
| Q1 2024 | 0.14 | 0.09 | 49.19% | 16.67% | 659.191M | 631.41M | 4.40% | 18.23% |
| Q4 2023 | 0.14 | 0.09 | 52.17% | -39.13% | 616.98M | 646.91M | -4.63% | 1.18% |
| Q3 2023 | 0.19 | 0.13 | 46.90% | 35.71% | 620.04M | 607.18M | 2.12% | 13.65% |
| Q2 2023 | 0.19 | 0.11 | 75.73% | - | 599.046M | 576.72M | 3.87% | 7.10% |
| Q1 2023 | 0.12 | 0.10 | 22.55% | - | 557.54M | 548.05M | 1.73% | 12.04% |
| Q4 2022 | 0.23 | 0.21 | 7.74% | 27.78% | 609.759M | 591.51M | 3.09% | 13.57% |
| Q3 2022 | 0.14 | 0.18 | -22.39% | -33.33% | 545.557M | 573.1M | -4.81% | 3.21% |
| Q2 2022 | 0.19 | 0.20 | -4.13% | -24.00% | 559.355M | 547.06M | 2.25% | 4.54% |
| Q1 2022 | 0.12 | 0.13 | -9.01% | -40.00% | 497.633M | 514.05M | -3.19% | 0.92% |
| Q4 2021 | 0.18 | 0.20 | -11.26% | 28.57% | 536.896M | 548.1M | -2.04% | 5.27% |
| Q3 2021 | 0.21 | 0.21 | 0.78% | 31.25% | 528.593M | 555.97M | -4.92% | 1.79% |
| Q2 2021 | 0.25 | 0.19 | 33.39% | 92.31% | 535.075M | 533.71M | 0.26% | 15.14% |
| Q1 2021 | 0.20 | 0.18 | 11.18% | - | 493.1M | 523.5M | -5.81% | -1.08% |
| Q4 2020 | 0.14 | 0.14 | 2.01% | - | 510M | 517.16M | -1.38% | - |
| Q3 2020 | 0.16 | 0.12 | 28.77% | - | 519.3M | 491.75M | 5.60% | - |
| Q2 2020 | 0.13 | 0.10 | 31.84% | - | 464.7M | 466.41M | -0.37% | - |
| Q1 2020 | 0.20 | 0.09 | 120.09% | - | 498.5M | 455.04M | 9.55% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
28.29%
Max EPS beat (4)
40.37%
Min EPS beat (4)
11.53%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-2.73%
Max Revenue beat (4)
-0.41%
Min Revenue beat (4)
-4.71%
Analysis
In the last 4 quarters, AMRX has consistently beaten EPS estimates in all releases
AMRX has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, AMRX has beaten the EPS estimates by 28.3% on average.
In the last 4 quarters, AMRX reported -2.7% below the revenue estimates on average.
Related analysis
AMNEAL PHARMACEUTICALS INC / AMRX Earnings FAQ
Did AMRX stock beat earnings estimates in the most recent quarter?
AMNEAL PHARMACEUTICALS INC (AMRX) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does AMNEAL PHARMACEUTICALS INC (AMRX) beat earnings estimates?
In the last 4 quarters, AMNEAL PHARMACEUTICALS INC (AMRX) has beaten EPS estimates in 4 out of 4 releases.